All Articles

PrintMail's new integration with Jack Henry's core systems offers a blueprint for efficiency, security, and the future of financial communication.

With at-home PCR tests and AI-driven insights, Petwealth is building a decentralized health network for pets, challenging the traditional vet care model.

One Times Square, home of the Ball Drop, just spent half a billion dollars to sell you its history. But in a city of spectacles, is this a time machine or just another trap?

A Swiss-Australian venture is bringing industrial-scale drones to the US. Their success hinges on more than just tech—it’s a test of regulatory will.

A Utah biotech's new blood test can identify the exact brain cells dying in diseases like Alzheimer's, a major leap beyond today's diagnostics.

Amid market turbulence, Andrew Farkas is forging a new powerhouse. The NAI Global deal isn't just a shuffle; it's a key move in a plan to master the downturn.

Indra’s major US transit contracts are more than just tech upgrades. They represent a calculated market entry backed by local manufacturing and high stakes.

AZIO AI Holdings is pivoting from EVs to AI infrastructure with a massive NVIDIA GPU deal. But can it navigate the financial risks to build the future?

DocHub's new 'Rooms' feature moves beyond simple PDF editing, offering a unified workspace for teams that could disrupt the competitive document management market.

With a fresh $30M and a potential $90M total, Femasys is poised to shake up women's health. But can it hit the milestones to unlock its full potential?

The new blank check company debuts with a $100M war chest. A deep dive into its leadership, complex structure, and what its launch means for investors.

With industry veteran Glen Fossella as its new CRO, Delfi is accelerating its mission to bring agentic AI for balance sheet intelligence to Main Street.

Eutelsat commits billions to build Europe's IRIS² satellite network, a bold move for strategic autonomy and a high-stakes bet against rivals like Starlink.

Lithuania's grid operator swung from a €42M loss to a €39M profit. Beyond the numbers lies a story of regulatory finesse and strategic investment fueling energy independence.

The American Society of Hematology names insider Matthew Gertzog as CEO, succeeding a 30-year leader. The move ensures continuity while prioritizing data-driven research.

A 130-year-old Japanese innovator is embedding Mt. Fuji lava into pet blankets. Is it a wellness revolution or a masterful story of corporate reinvention?

For a rare brain disease with no cure, a revolutionary trial design offers a faster path to treatment and renewed hope for thousands of patients and families.

Breakaway Festival and BELLA+CANVAS are turning souvenirs into interactive experiences, creating a powerful new playbook for fan loyalty and brand growth.

HeartCore Enterprises sells its Vietnamese software venture for a modest sum, signaling a major strategic shift to its high-stakes IPO consulting business.

The Sun Rose West Hollywood replaces a celebrity chef concept with two specialized restaurants, a strategic pivot aiming to dominate a fiercely competitive market.